“Baseline risk assessment for cardiotoxicity – when, what tools, who does it?”
Join us virtually for our inaugural quarterly webinar in collaboration with the Canadian Cardiovascular Society and the Ted Rogers Centre for Heart Research.
Date & Time: Friday, February 23, 2024 | 12:00 - 1:00 p.m. EST
Speakers: Dr. Moira Rushton & Dr. Husam Abdel-Qadir
Learning Objectives:
- Examine oncology treatments that are associated with cardiotoxicity
- Identify which patients are at increased risk of cardiotoxicity
- Develop an approach for baseline assessment of CVD risk in cancer patients
- Discuss appropriate timing for cardiology referral for cancer patients at risk of cardiotoxicity